Financials
Cash Data
- Monthly Burn
- Burn Trend
- Dilution Risk
- SEC Filing
Key Stats
Upcoming Catalysts
FDA decisions, readouts and PDUFA dates · scored by probability of approval
| Catalyst | Drug / Treatment | Stage | Prob. of Approval | Description | Drug Type | Therapeutic Area | Source |
|---|
GRDN Catalyst Timeline
Dated clinical, regulatory and corporate events for Guardian Pharmacy Services, Inc.
Catalyst Timeline
Dated clinical, regulatory & corporate events for Guardian Pharmacy Services, Inc.
Event history 1
Past FDA Catalysts and PDUFA Decisions
How GRDN actually traded into and out of each decision
| Date | Drug | Catalyst | Stage | Reaction | Event Move % | Best Trade % |
|---|---|---|---|---|---|---|
| No matching catalysts | ||||||
Drug Pipeline Intelligence
No drug pipeline
Guardian Pharmacy Services, Inc. is not a drug developer. The clinical trials it takes part in test other companies' drugs, so it has no drug pipeline of its own to score.
Clinical Trial Results
Readouts, endpoints and source filings for every GRDN program
| Drug Name | Indication | Phase | Date | Trial Results Summary | Title | Source |
|---|
Inside Trades
| Insider | Side | Shares | Price | Value | Date |
|---|---|---|---|---|---|
| Towns DouglasOfficer (See Remarks) | Option | 23,450 113,006 held | $0.00 | 09/27/2026 |
Hedge Fund 13F Activity
Hedge Funds invested in GRDN
| Fund | % of Portfolio | Current MV | Shares Owned | Activity |
|---|---|---|---|---|
| No hedge fund reported a 13F position in GRDN for Q2 2026. | ||||
Ownership Trends
GRDN Short Interest
Shares sold short, counted twice a month.
Options Data
Option Volume
Option Chain Statistics
| Expiry | Call Vol | Put Vol | Vol P/C | Call OI | Put OI | OI P/C | IV Call | IV Call OI-Wtd | IV Call Vol-Wtd | IV Put | IV Put OI-Wtd | IV Put Vol-Wtd |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-11-20 | ||||||||||||
Real-Time Option Chain
| Calls | Strike | Puts | ||||
|---|---|---|---|---|---|---|
| Last | Vol | OI | Last | Vol | OI | |
| No data available | ||||||
Calls vs Puts by Expiry
Competitive positioning
How GRDN ranks across every disease it competes in
GRDN News
Guardian Pharmacy Services, Inc. to Participate in Upcoming Citi Annual Global Healthcare Conference
Guardian Pharmacy Services, Inc. will attend the Citi 2026 Global Healthcare Conference in Miami on December 1, 2026. CEO Fred Burke is scheduled to participate in a fireside chat at 2:20 p.m. EST. The event will be accessible via a live audio webcast for investors and the public.
Read more →Guardian Pharmacy Services Reports Third Quarter 2026 Financial Results; Raises Full-Year Guidance
Guardian Pharmacy Services reported strong third-quarter results for 2026, with revenues of $371.1 million and net income of $19.1 million. The company raised its full-year guidance, citing organic growth and margin improvements. CEO Fred Burke emphasized the positive outlook and the company's strategic acquisitions to enhance growth.
Read more →Guardian Pharmacy Services Acquires Van’s Institutional Pharmacy, Expanding Footprint in Tennessee and Kentucky
Guardian Pharmacy Services has acquired Van's Institutional Pharmacy, expanding its operations in Tennessee. This acquisition increases Guardian's presence to five pharmacies in the state, enhancing its ability to meet the growing demand for long-term care pharmacy services. Van's will continue to operate under its name, with its existing leadership remaining in place.
Read more →Guardian Pharmacy Services, Inc. to Participate in Upcoming Stephens Investment Conference
Guardian Pharmacy Services, Inc. will attend the Stephens Investment Conference on November 18, 2026. CEO Fred Burke is scheduled to participate in a fireside chat at 9:30 a.m. CST. Investors and the public can access a live audio webcast of the presentation via the company's website. Guardian operates 61 licensed pharmacies, serving about 210,000 residents.
Read more →Guardian Pharmacy Services, Inc. to Report Third Quarter 2026 Financial Results and Host Conference Call
Guardian Pharmacy Services, Inc. announced it will release its third quarter 2026 financial results on November 5, 2026. A conference call will follow at 4:30 p.m. Eastern Time to discuss these results. Participants can join via audio webcast or by phone.
Read more →Guardian Pharmacy Services Acquires Assets of Tennessee-Based Nautilus Pharmacy
Guardian Pharmacy Services, Inc. has successfully acquired the assets of Nautilus Pharmacy, based in Tennessee. This acquisition is expected to enhance Guardian's service offerings and strengthen its market position. The move reflects Guardian's strategy to expand its portfolio and improve its operational capabilities.
Read more →Guardian Pharmacy Services, Inc., to Participate in Upcoming Jefferies Healthcare Services Investor Conference
Guardian Pharmacy Services, Inc. will participate in the Jefferies Healthcare Services Conference on September 15, 2026. CEO Fred Burke is scheduled for a fireside chat at 2:25 p.m. CST. The event is open to investors, analysts, and the public via a live audio webcast.
Read more →Guardian Pharmacy Services Reports Second Quarter 2026 Financial Results; Raises Full-Year Guidance
Guardian Pharmacy Services, Inc. reported its financial results for the second quarter of 2026, showing a revenue increase of 2% year-over-year, totaling $351.8 million. The company served approximately 210,000 residents, marking an 8% growth compared to the previous year. Additionally, Guardian raised its full-year guidance, reflecting a positive outlook.
Read more →Guardian Pharmacy Services, Inc. to Report Second Quarter 2026 Financial Results and Host Conference Call
Guardian Pharmacy Services, Inc. has announced the release of its second quarter 2026 financial results, which will occur after market close on August 6, 2026. The company will also host a conference call at 4:30 p.m. Eastern Time to discuss these results. Investors can access the call via audio webcast or by phone.
Read more →Guardian Pharmacy Services Expands Virginia Footprint With Acquisition of Wellness Concepts
Guardian Pharmacy Services has announced the expansion of its operations in Virginia through the acquisition of Wellness Concepts. This move is part of Guardian's strategy to enhance its service offerings in the region. The acquisition aims to strengthen Guardian's market presence and improve access to pharmacy services for clients in Virginia.
Read more →Guardian Pharmacy Services, Inc. Announces Leadership Transitions
Guardian Pharmacy Services, Inc. has announced leadership transitions within the company. The details of these changes were not specified in the article. The announcement indicates a potential shift in company strategy or operations. Further information may be released in the future regarding the new leadership roles.
Read more →Guardian Pharmacy Services Announces Senior Leadership Promotions to Support Continued Growth and Operational Alignment
Guardian Pharmacy Services announced several senior leadership promotions to enhance operational alignment and support growth. Key promotions include Will Mudd as SVP of Finance and Doug Towns as SVP of General Counsel. The company aims to maintain service consistency across its national network while emphasizing local pharmacy leadership.
Read more →Guardian Pharmacy Services Reports First Quarter 2026 Financial Results; Updates Full-Year Guidance
Guardian Pharmacy Services has released its financial results for the first quarter of 2026 and has updated its guidance for the full year. The report indicates ongoing operations but lacks specific details on financial performance or strategic initiatives. The company aims to provide clearer insights as the year progresses.
Read more →Guardian Pharmacy Services, Inc. to Participate in the Bank of America 2026 Healthcare Conference
Guardian Pharmacy Services, Inc. will attend the Bank of America 2026 Healthcare Conference in Las Vegas on May 13, 2026. CEO Fred Burke will participate in a fireside chat at 9:20 a.m. PDT. The event is accessible via a live audio webcast on the company's website, promoting transparency and engagement with stakeholders.
Read more →Guardian Pharmacy Services, Inc. to Report First Quarter 2026 Financial Results and Host Conference Call
Guardian Pharmacy Services, Inc. is set to report its financial results for the first quarter of 2026. The company will also host a conference call to discuss these results with stakeholders. Further details about the financial performance and insights are expected during the call.
Read more →Guardian Pharmacy Services Reports Fourth Quarter and Full Year 2025 Financial Results; Raises 2026 Adjusted EBITDA Guidance
Guardian Pharmacy Services, a leading provider of long-term care pharmacy services, announced its financial results for the fourth quarter and full year of 2025, showcasing strong growth across revenue and Adjusted EBITDA. The company raised its Adjusted EBITDA guidance for 2026, reflecting positive business momentum and operational efficiencies. Additionally, Guardian expanded its full-service pharmacy count with the acquisition of North Ridge Pharmacy, contributing to an overall increase in service capacity and operational performance. The results indicate a focus on long-term sustainable value for shareholders, despite acknowledging the impact of new drug pricing changes scheduled for 2026.
Read more →Guardian Pharmacy Services Reiterates 2025 Guidance and Provides 2026 Outlook
Guardian Pharmacy Services has reiterated its 2025 guidance while providing a preliminary outlook for 2026, expecting low double-digit adjusted EBITDA growth. The company anticipates revenue between $1.40 billion and $1.42 billion for 2026, despite drug pricing reforms. CEO Fred Burke emphasized the company's commitment to maintaining care quality while adapting to market changes.
Read more →Guardian Pharmacy Services Reports Third Quarter 2025 Financial Results
Guardian Pharmacy Services reported strong financial results for the third quarter of 2025, marking a successful inaugural year as a public company. The company's revenue guidance was raised to between $1.43 billion and $1.45 billion, alongside an increase in Adjusted EBITDA guidance. The expansion into the Pacific Northwest through the acquisition of Managed Healthcare Pharmacy highlights Guardian's growth strategy. The firm also filed a shelf registration statement, allowing for future financing strategies.
Read more →Smarter Growth, Better Service Disclaimers Forward-Looking Statements: This presentation (including oral commentary that accompanies this presentation) has been prepared by Guardian Pharmacy Services, Inc. ("Guardian," t
Guardian Pharmacy Services has issued a presentation outlining its forward-looking statements and business strategy. The company emphasizes its market leadership with more than 40% market share, particularly in the Assisted Living and Memory Care pharmacy markets. However, the presentation also highlights various risks and uncertainties facing the company, including competition, regulatory changes, and supply chain disruptions. The management team possesses substantial experience that could foster effective execution of their strategies despite the outlined challenges.
Read more →Guardian Pharmacy Services Reports Second Quarter 2025 Financial Results; Raises Full-Year Guidance
Guardian Pharmacy Services announced its strong financial results for the second quarter of 2025, demonstrating solid growth across multiple metrics. The company raised its full-year revenue and adjusted EBITDA guidance, reflecting better-than-expected performance and effective execution by pharmacy teams. Recent acquisitions in key markets contribute to the anticipated growth, positioning Guardian favorably within the long-term care pharmacy sector. The organization also completed a secondary offering, increasing its public float.
Read more →